0 Commentaires
0 Parts
365 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Meningococcal Vaccines Market Forecast: Industry Developments, Demand, and Growth ProspectsThe Meningococcal Vaccines Market is expected to experience continued growth as healthcare systems prioritize infectious disease prevention and vaccine innovation. Market Research Future projects that the market will rise from USD 3.34 billion in 2025 to USD 6.48 billion by 2035, registering a CAGR of 7.62% during 2026–2035. Future growth will be shaped by improvements in vaccine...0 Commentaires 0 Parts 265 Vue 0 Aperçu
-
South America Meningococcal Vaccines Market Growth, Competitive Landscape & Forecast Report 2035The South America Meningococcal Vaccines Market is experiencing steady growth as governments, healthcare organizations, and vaccine manufacturers intensify efforts to prevent meningococcal disease across the region. Meningococcal vaccines play a vital role in protecting individuals from severe bacterial infections caused by Neisseria meningitidis, which can lead to meningitis and bloodstream...0 Commentaires 0 Parts 323 Vue 0 Aperçu
-
Meningococcal Polysaccharide Vaccine Market to Reach USD 4.5 Billion by 2030 | CAGR 6.3%According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030. Meningococcal polysaccharide vaccines are immunogenic preparations...0 Commentaires 0 Parts 795 Vue 0 Aperçu
-
Meningococcal Vaccines Market Analysis of Established and Emerging SegmentsThe Meningococcal Vaccines Market is projected to increase from USD 4.4 billion in 2026 to USD 5.9 billion by 2033, registering a CAGR of 4.5%. After reaching USD 4.1 billion in 2025, the Meningococcal Vaccines Market is entering a period in which growth opportunities vary considerably across vaccine brands, serogroups, age groups, and geographies. Rather than following one uniform trajectory,...0 Commentaires 0 Parts 88 Vue 0 Aperçu